Cytokinetics CYTK Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's prepaid & other current?
- Cytokinetics (CYTK) reported prepaid & other current of $13.93M in Q1 2026.
- How has Cytokinetics's prepaid & other current changed year-over-year?
- Cytokinetics's prepaid & other current decreased by 11.9% year-over-year, from $15.82M to $13.93M.
- What is the long-term trend for Cytokinetics's prepaid & other current?
- Over 5 years (2020 to 2025), Cytokinetics's prepaid & other current has grown at a 24.2% compound annual growth rate (CAGR), from $5.74M to $16.99M.
- What does prepaid & other current mean?
- Assets resulting from payments made in advance for future services or other minor short-term resources.
- How do you interpret prepaid & other current?
- Significant fluctuations may indicate changes in the scale of operational contracts or timing of large research-related prepayments.
- How does prepaid & other current compare across companies?
- Standard across all industries; levels are generally proportional to the size of the company's operational footprint.